Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
PSIL
30
HOLDINGS
27%
ALSO IN IBRN
IBRN
58
HOLDINGS
8%
ALSO IN PSIL
SECTOR DRIFT (PSIL minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSIL |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 4.7% | 4.1% | 4.1% |
 |
SUPERNUS PHARMACEUTICALS INC | 7.7% | 3.7% | 3.7% |
|
NEUROCRINE BIOSCIENCES INC | 4.5% | 3.5% | 3.5% |
PSIL Overweight Relative to IBRN
 |
ATAI LIFE SCIENCES N.V. | 12.2% |
|
RELMADA THERAPEUTICS INC | 8.4% |
|
ALTO NEUROSCIENCE INC | 4.4% |
|
SUPERNUS PHARMACEUTICALS INC | 3.9% |
|
ABBVIE INC | 3.6% |
|
JOHNSON & JOHNSON | 3.4% |
|
NEURONETICS, INC. | 2.0% |
|
INCANNEX HEALTHCARE INC. | 1.3% |
|
NEUROCRINE BIOSCIENCES INC | 1.0% |
 |
NUMINUS WELLNESS INC | 1.0% |
PSIL Underweight Relative to IBRN
|
AXSOME THERAPEUTICS, INC. | -4.6% |
|
BIOGEN IDEC INC | -4.2% |
|
PTC THERAPEUTICS INC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -3.9% |
|
SCHOLAR ROCK HOLDING CORP. | -3.8% |
 |
ARGENX SE ADR | -3.5% |
|
CATALYST PHARMACEUTICAL PART | -3.4% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.2% |
|
SAREPTA THERAPEUTICS INC | -3.1% |
|
DENALI THERAPEUTICS INC. | -3.0% |